3Goldman JG, Litvan I. Mild cognitive impairment in Parkinson' s disease [J]. Minerva Med, 2011, 102 (6): 441 -459.
4Petersen RC, Smith GE, Waring SC, et at. Mild cog- nitive impairment : clinical characterization and outcome [J]. Arch Neurol, 1999, 56 (3): 303-308.
5Litvan I, Goldman JG, Troster AI, et at. Diagnostic criteria for mild cognitive impairment in Parkinson' s disease: movement disorder society task force guidelines [J]. Mov Disord, 2012, 27 (3): 349-356.
6Lee J, Giordano S, Zhang J. Autophagy, mitoehon- dria and oxidative stress: cross -talk and redox signal- ling [J]. Biochem J, 2012, 441 (2): 523-540. impairment : ten years later [ J ]. Arch Neu- rol, 2009, 66 (12): 1447- 1455.
7Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson' s dis- ease: critical review of PD - MCI [J] . Mov Disord , 2011, 26 (10): 1814-1824.
8Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment : ten years later [ J ]. Arch Neu- rol, 2009, 66 (12): 1447- 1455.
9Jellinger K. Heterogenous mechanisms of mild cognitive impairment in Parkinson' s disease [ J ]. J Neural Transm, 2012, 119 (3): 381-382.
10Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and de- mentia in Parkinson disease [ J ]. Neurology, 2009, 73 (21): 1738 -1745.
